# ClinicalTrials.gov record NCT06305598

> PeptideScanner retained ClinicalTrials.gov record NCT06305598 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct06305598-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06305598-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06305598-leuprolide-v1.json
- Content SHA-256: `71bdc5cf1231a0d31ccd1242b6acbd6ab7b30791fadfa6255994a52002fb1f5f`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06305598 ([`ctg-observation-nct06305598-2026-06-10-01908f3269bc`](#source-ctg-observation-nct06305598-2026-06-10-01908f3269bc))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06305598 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct06305598-2026-06-10-01908f3269bc`](#source-ctg-observation-nct06305598-2026-06-10-01908f3269bc))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06305598 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct06305598-2026-06-10-01908f3269bc`](#source-ctg-observation-nct06305598-2026-06-10-01908f3269bc))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06305598-2026-06-10-01908f3269bc`](#source-ctg-observation-nct06305598-2026-06-10-01908f3269bc))

## Sources

<a id="source-ctg-observation-nct06305598-2026-06-10-01908f3269bc"></a>
- **ClinicalTrials.gov record NCT06305598 · retained source version 2026-06-10:01908f3269bc2e7dc30d5041ed4713e2cd017a5b247ed07849344b4d7da30b4c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06305598) (`ctg-observation-nct06305598-2026-06-10-01908f3269bc`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06305598." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06305598-leuprolide-v1.json SHA-256: 71bdc5cf1231a0d31ccd1242b6acbd6ab7b30791fadfa6255994a52002fb1f5f.